Vivek Subbiah

2 months ago | onclive.com | Vivek Subbiah |Lucio N. Gordan

OpinionVideoFebruary 17, 2025Author(s):,Panelists discuss how in this discussion the top 3 key points were patient-centric care, enhanced multidisciplinary coordination, and increased access and equity. In the next 3 to 5 years there will be more decentralized testing, potentially more practices participating in genomic profiling, the cost of testing will go down and the turnaround time will be shorter.

2 months ago | onclive.com | Vivek Subbiah |Lucio N. Gordan

OpinionVideoFebruary 10, 2025Author(s):,Panelists discuss how decentralizing testing can address socioeconomic disparities by improving access to diagnostics for underserved populations. In-house testing reduces barriers like transportation challenges, lack of insurance, and limited availability of specialized tests, ensuring timely, equitable health care for all communities.

2 months ago | onclive.com | Vivek Subbiah |Lucio N. Gordan

OpinionVideoFebruary 10, 2025Author(s):,Panelists discuss how decentralizing biomarker testing improves access to targeted therapies and clinical trials for underserved populations by reducing geographic and systemic barriers, fostering equity in cutting-edge health care. Video series above is prompted by the following:What are your thoughts on how decentralization of biomarker testing might address access to targeted therapies and clinical trials in underserved populations?

2 months ago | onclive.com | Vivek Subbiah |Lucio N. Gordan

OpinionVideoFebruary 3, 2025Author(s):,Panelists discuss how in-house laboratory testing has demonstrated significant advantages in patient care through rapid turnaround times and immediate decision-making capabilities. Emergency departments have seen notably improved outcomes when critical tests like cardiac markers and blood gases are performed on-site, enabling faster treatment initiation for acute conditions.

2 months ago | onclive.com | Vivek Subbiah |Lucio N. Gordan

OpinionVideoFebruary 3, 2025Author(s):,Panelists discuss how in-house testing facilities significantly enhance multidisciplinary coordination by enabling rapid result turnaround and real-time treatment adjustments. This streamlined process facilitates immediate care planning among specialists, leading to faster clinical decisions and reduced wait times.